A smart P-gp inhibitor-drug conjugate nanomedicine overcomes administration challenges and multidrug resistance in breast cancer therapy

Docetaxel (DTX), a first-line taxane chemotherapeutic agent, is widely used in the treatment of breast cancer. However, its clinical efficacy is often limited by multidrug resistance (MDR), primarily driven by...

Authors

Yingchun Liu (ORCID: https://orcid.org/0000-0002-6141-363X)
Wenhui Gao (ORCID: https://orcid.org/0000-0001-9501-885X)
Penghui Wang
Deyue Yan
Yao Wang
Wei Hsiang Huang
Xuelin Xia

Publication Details

Journal: Biomaterials Science
Published: 2026-01-01
DOI: https://doi.org/10.1039/d6bm00280c
Primary Topic: Drug Transport and Resistance Mechanisms
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A smart P-gp inhibitor-drug conjugate nanomedicine overcomes administration challenges and multidrug resistance in breast cancer therapy

Yingchun Liu, Wenhui Gao, Penghui Wang, Deyue Yan et al.

Jan 1, 2026

Biomaterials Science

Drug Transport and Resistance Mechanisms

article

A smart P-gp inhibitor-drug conjugate nanomedicine overcomes administration challenges and multidrug resistance in breast cancer therapy

Yingchun Liu, Wenhui Gao, Penghui Wang, Deyue Yan, Yao Wang, Wei Hsiang Huang, Xuelin Xia

January 1, 2026article en

Abstract

Biomaterials Science

Good health and well-being

Openalex Percentile: Top 8%

Drug Transport and Resistance Mechanisms

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A smart P-gp inhibitor-drug conjugate nanomedicine overcomes administration challenges and multidrug resistance in breast cancer therapy — Yingchun Liu, Wenhui Gao, et al. · Biomaterials Science (2026) | TGRS Research Map | TGRS